Complement activation by extracorporeal circulation: effects of precoating a membrane oxygenator circuit with human whole blood

References

• Baier R E. The organization of blood components near interfaces. Ann NY Acad Sci 1977; 283: 17–36
   Web of Science ®Google Scholar
• Balzo U HD, Levi R, Polley M J. Cardiac dysfunction caused by purified human C3a anaphylatoxin. Proc Natl Acad Sci USA 1985; 82: 886–890
   Google Scholar
• Basse-Cathalinat B, Baquey C, Llabador Y, Fleury A. Direct in vivo study of flowing blood-artificial surface interactions—an original application of dynamic isotopic techniques. Int J Appl Radiat Isot 1980; 31(12)747–751
   Google Scholar
• Bhakdi S, Fassbender W, Hugo F, Berstecher C, Malasit P, Careno M P, Kazatchkine M. Relative inefficiency of terminal complement activation in the fluid phase. Complement 1987; 4: 134–135, (Abstract)
   Google Scholar
• Breillatt J, Dorson W J. Quantification of serum complement activation by polymeric membranes and materials. J Am Soc Artif Int Org 1984; 7: 57–63
   Google Scholar
• Chenoweth D E, Cooper S W, Hugli T E, Stewart R W, Blackstone E H, Kirklin J W. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304(9)497–502
   PubMed Web of Science ®Google Scholar
• Collett B, Alhaq A, Abdullah N B, Korjtsas L, Ware R J, Dodd N J, Alimo E, Ponte J, Vergani D. Pathways to complement activation during cardiopulmonary bypass. Br Med J 1984; 289: 1251–1254
   PubMed Web of Science ®Google Scholar
• Conover W J. Practical nonparametric statistics2nd ed. Wiley, New York 1980; 229–237; 299–308
   Google Scholar
• Doutremepuich C. Interactions sang bio-materiaux: applications a la circulation extra-corporelle. Pathol Biol 1982; 30(8)677–679
   Google Scholar
• Ferries L H, Marx J J, Ray J F. The effect of methylpred nisolone on complement activation during cardiopulmonary bypass. J Extracorp Tech 1984; 16(3)83–88
   Google Scholar
• Fosse E, Mollnes T E, østerud A, Aasen A O. Effects of methylprednisolone on complement activation and leukocyte counts during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1987, in press
   Google Scholar
• Garred P, Mollnes T E, Lea T. Quantification in ELISA of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol
   Google Scholar
• Grode G A, Falb R D, Crowley J P. Biocompatible materials for use in the vascular system. J Biomed Mater Res 1972; 6: 77–84
   Google Scholar
• Guidoin R G, Awad J A, Laperche Y, Morin P J, Haggis G H. Nature of deposits in a tubular membrane oxygenator after prolonged extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 69(3)479–491
   Google Scholar
• Hakim R M, Breillatt J, Lazarus J M, Port F K. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311(14)878–882
   Google Scholar
• Hammerschmidt D E, Harnes P E, Wayland J H, Craddock P R, Jacob H S. Complement-induced granulocyte aggregation in vivo. Am J Pathol 1981; 102: 146–150
   PubMed Web of Science ®Google Scholar
• Jacob H S, Craddock P R, Hammerschmidt D E, Moldow C F. Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 1980; 302(14)789–794
   PubMed Web of Science ®Google Scholar
• Kazatchkine M D, Fearon D T, Austen K F. Human alternative complement pathway: Membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J Immunol 1979; 122: 75–81
   PubMed Web of Science ®Google Scholar
• Kurusz M, Christman E W, Williams E H, Tyers G FO. Roller pump induced tubing wear: Another argument in favor of arterial line filtration. J Extracorp Tech 1980; 12(2)49–59
   Google Scholar
• Kurusz M, Williams D R. Blood surfaces in the extracorporeal circuit: A scanning electron microscopy study. J Extracorp Tech 1975; 7(4)186–198
   Google Scholar
• Moeschin S. Klinik und Therapie der Vergiftungen. Georg Thieme Verlag, Stuttgart 1980; 16–17; 94
   Google Scholar
• Mollnes T E. Early- and late-phase activation of complement evaluated by plasma levels of C3d.g and the terminal complement complex. Complement 1985; 2: 156–164
   Google Scholar
• Mollnes T E, Lea T, Frøland S S, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against neoantigen of the complex. Scand J Immunol 1985; 22: 197–202
   PubMed Web of Science ®Google Scholar
• Oeveren W V, Kazachkine M D, Decamps-Latscha B, Maillet F, Fischer E, Carpentier A, Wildevuir G RH. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thor Cardiovasc Surg 1985; 89: 888–899
   Google Scholar
• Pangburn M K, Schreiber R D, Müller-Eberhardt H J. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J Immunol 1983; 131: 1930–1935
   PubMed Web of Science ®Google Scholar
• Salzman E W, Lindon J, Brier D. Surface-induced platelet adhesion, aggregation, and release. Ann NY Acad Sci 1977; 283: 114–127
   Web of Science ®Google Scholar
• Stroncek D F, Keshaviah P, Craddock P R, Hammerschmidt D E. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis. J Lab Clin Med 1984; 104: 304–311
   PubMed Web of Science ®Google Scholar
• Vroman L, Adams A L, Klings M, Fischer G C, Munoz P C, Solensky R P. Reactions to formed elements of blood with plasma proteins at interfaces. Ann NY Acad Sci 1977; 283: 65–76
   Web of Science ®Google Scholar